Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
研究类风湿关节炎发生和进展过程中的粘膜破裂
基本信息
- 批准号:10436924
- 负责人:
- 金额:$ 62.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-23 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntibodiesAntibody RepertoireAntigen TargetingAntigen-Antibody ComplexAntigensArthritisAutoimmuneAutoimmune ResponsesAutoimmunityB-LymphocytesBacteremiaBacteriaBacterial AntibodiesBacterial DNABloodCitrullineClinicalCollectionDNADNA sequencingData SetDental CareDevelopmentDiseaseEnvironmental ExposureEnvironmental Risk FactorEnzyme-Linked Immunosorbent AssayExhibitsFamilyFingersFlareGingival PocketHomeHumanHuman CharacteristicsIL6 geneImmune responseImmunoglobulin AImmunoglobulin GImmunoglobulin Somatic HypermutationIn VitroInterleukin-6JointsLeadLeukocyte ElastaseLymphocyte SubsetLymphocytic InfiltrateMeasurementMeasuresMediatingMonitorMucous MembraneNucleotidesOralOral cavityOral mucous membrane structureOsteoclastsPRTN3 genePatientsPeptide antibodiesPeriodontal DiseasesPeriodontal PocketPeriodontitisPlasmablastPlayPopulationProductionProtein IsoformsProtocols documentationReactionRecombinantsRheumatoid ArthritisRoleSamplingSignal TransductionSiteSpecificityStainsStructure of germinal center of lymph nodeSynovial MembraneSynovitisT cell responseT-LymphocyteTNF geneTestingTissuesVenouscigarette smokingcitrullinated proteincohortcross reactivitycyclic citrullinated peptidemacrophagememberneutrophilnovel diagnosticsnovel strategiesnovel therapeutic interventionoral bacteriaosteoclastogenesispathogenpre-clinicalpreventresponsesample collectionseropositivesingle-cell RNA sequencingsuccesstranscriptome sequencing
项目摘要
Rheumatoid arthritis (RA) is an autoimmune synovitis that affects 0.5% of the world population. RA is
characterized by intermittent flares of clinical arthritis that is thought to be mediated in part by anti-
citrullinated protein autoimmune responses. The best established environmental risk factors for developing
RA include cigarette smoking and periodontal disease, suggesting oral mucosa is a critical site for disease
initiation. Nevertheless, the mechanisms by which these environmental exposures lead to RA development
and progression remain poorly understood. We have established a clinical and technical protocol for
repeated home finger stick blood collection in RA patients to allow for longitudinal RNA sequencing
(RNAseq). Using this novel approach, we recently discovered bacteria characteristic of human oral mucosa
in the blood of anti-CCP+ RA patients, followed by activation of a signature B cell immune response 3 weeks
later, and then clinical flare of disease activity 2 weeks after that. We also investigated B cell responses to
these pathogens. We demonstrated elevations in IgA blood plasmablasts both in pre-clinical RA as well as
in established RA, with the continual re-activation of a distinct set of IgA/IgG plasmablast clonal families in
established RA suggesting a persistent mucosally-driven germinal center reaction. We demonstrate that the
recombinant Mabs encoded by the persistently reactivated IgA/G plamablast clonal families encode
antibodies that react with both human citrullinated antigens and citrullinated isoforms of oral bacteria
identified in the blood of patients antecedent to flares. We anticipate that RA plasmablast Mabs with distinct
specificities, either alone or in immune complexes, mediate activation of distinct cellular responses that
promote synovitis and tissue destruction in RA. This R01 proposal will test the hypothesis that mucosal
breaks trigger plasmablast responses that encode anti-bacterial antibodies that cross-react with host
citrullinated antigens. We further hypothesize that mucosal bacteria-induced ACPA activate cellular
responses, including macrophage TNF production, NETosis and osteoclast activation, which promote
synovitis and joint tissue destruction in RA. Aim 1 will identify the antibody repertoires responsive to pre-flare
bacteremia in two independent cohorts of RA patients. Aim 2 will characterize RA plasmablast IgA/G Mabs
and sera for reactivity to citrullinated isoforms of bacterial species derived from subgingival collections. Aim 3
will characterize periodontitis tissue for evidence of RA-related autoimmunity. Aim 4 will determine the
mechanisms by which cross reactive Mabs, either alone or in immune complexes, mediate arthritis. Success
of this proposal would demonstrate that citrullinated periodontal bacteria and mucosal breaks play a key role
in mediating RA flare, findings that could lead to development of new diagnostic and therapeutic approaches.
风湿性关节炎(RA)是一种自身免疫性滑膜炎,影响世界人口的0.5%。RA是
其特征在于临床关节炎的间歇性发作,其被认为部分由抗-
瓜氨酸蛋白自身免疫反应。发展中国家的最佳环境风险因素
RA包括吸烟和牙周病,表明口腔粘膜是疾病的关键部位
入会仪式然而,这些环境暴露导致RA发展的机制
和进展仍然知之甚少。我们已经建立了一个临床和技术协议,
在RA患者中重复家庭手指针刺采血以允许纵向RNA测序
(RNAseq)。利用这种新方法,我们最近发现了人类口腔粘膜的细菌特征,
在抗CCP + RA患者的血液中,随后激活标志性B细胞免疫应答3周
之后,然后在2周后出现疾病活动的临床发作。我们还研究了B细胞对
这些病原体。我们证实了临床前RA和RA患者伊加浆母细胞的升高,
在已建立的RA中,随着一组独特的伊加/IgG浆母细胞克隆家族的持续重新激活,
建立了RA,表明持续的粘膜驱动的生发中心反应。我们证明了
由持续再活化的伊加/G浆母细胞克隆家族编码的重组单克隆抗体编码
与人瓜氨酸化抗原和口腔细菌的瓜氨酸化同种型反应的抗体
在耀斑爆发前的患者血液中发现。我们预期RA浆母细胞单克隆抗体具有不同的
特异性,无论是单独或在免疫复合物中,介导不同细胞反应的激活,
促进RA中的滑膜炎和组织破坏。本R 01提案将检验粘膜
断裂触发浆母细胞应答,浆母细胞应答编码与宿主交叉反应的抗菌抗体
瓜氨酸化抗原。我们进一步假设,粘膜细菌诱导的ACPA激活细胞
反应,包括巨噬细胞TNF产生,NETosis和破骨细胞活化,这促进了
滑膜炎和关节组织破坏。目的1将确定对预爆发有反应的抗体库
两个独立的RA患者队列中的菌血症。目的2将表征RA浆母细胞伊加/G单克隆抗体
以及血清对来自龈下收集物的细菌物种的瓜氨酸化同种型的反应性。目标3
将表征牙周炎组织中RA相关自身免疫的证据。目标4将决定
交叉反应性单克隆抗体单独或以免疫复合物形式介导关节炎的机制。成功
这一提议的结果将证明瓜氨酸化牙周细菌和粘膜破损发挥关键作用,
在介导类风湿性关节炎发作,发现可能导致新的诊断和治疗方法的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dana Elizabeth Orange其他文献
Dana Elizabeth Orange的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dana Elizabeth Orange', 18)}}的其他基金
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
研究类风湿关节炎发生和进展过程中的粘膜破裂
- 批准号:
10615760 - 财政年份:2021
- 资助金额:
$ 62.96万 - 项目类别:
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
研究类风湿关节炎发生和进展过程中的粘膜破裂
- 批准号:
10212156 - 财政年份:2021
- 资助金额:
$ 62.96万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 62.96万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 62.96万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 62.96万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别: